Session 2 | From promotion to strategic influence: attracting investment in health and life sciences
Dec 9, 2026 | 10:40 AM - 11:55 AM
CC9
Description
Health and life sciences have emerged as a top priority sector for IPAs across OECD countries, reflecting their central role in economic resilience, innovation and societal well-being. This session will explore how IPAs can strengthen their approach to attracting investment across the health value chain, including pharmaceuticals, medical technologies, biotechnology and digital health. What makes a health ecosystem attractive to investors? How can agencies facilitate linkages with research institutions, hospitals and innovation clusters? And how can investment promotion contribute to both competitiveness and resilience in the health sector?
